N-[5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]acetamide
Product Information
Molecular Formula
C13H19BN2O3
Molecular Weight
262.113
Description
N-[5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]acetamide is a remarkable biomedical versatile compound that holds significant promise in combating select diseases. Demonstrating its power as an impressive inhibitor, it effectively thwarts the progression of these ailments by specifically targeting and neutralizing crucial enzymes.
Synonyms
N-[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridyl]acetamide
IUPAC Name
N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]acetamide
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CN=C(C=C2)NC(=O)C
InChI
InChI=1S/C13H19BN2O3/c1-9(17)16-11-7-6-10(8-15-11)14-18-12(2,3)13(4,5)19-14/h6-8H,1-5H3,(H,15,16,17)
InChI Key
YCWPTBAHVWJMEY-UHFFFAOYSA-N
Melting Point
130-134 °C
Flash Point
Not applicable
Purity
97%
Safety Information
Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
2
Exact Mass
262.1488726 g/mol
Monoisotopic Mass
262.1488726 g/mol
Topological Polar Surface Area
60.4Ų
Heavy Atom Count
19
Formal Charge
0
Complexity
344
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| US-2020361939-A1 | Modulators of alpha-1 antitrypsin | 2019-05-14 |
| TW-202104223-A | Phosphatidylinositol 3-kinase inhibitors | 2019-04-10 |
| CN-114025756-A | Phosphatidylinositol 3-kinase inhibitors | 2019-04-10 |
| KR-20210150491-A | Phosphatidylinositol 3-kinase inhibitor | 2019-04-10 |
| US-2019076401-A1 | Cyanoindazole compounds and uses thereof | 2017-09-08 |
| US-10722495-B2 | Cyanoindazole compounds and uses thereof | 2017-09-08 |
| EA-038109-B1 | INHIBITORS OF WDR5 PROTEIN BINDING WITH PROTEINS | 2016-03-01 |
| KR-20180025896-A | As IRAK-4 inhibitors, indazole and azindazole compounds | 2015-07-15 |
| US-2018201609-A1 | Indazole and azaindazole compounds as irak-4 inhibitors | 2015-07-15 |
| US-10266532-B2 | Tricyclic modulators of TNF signaling | 2015-04-17 |
